Häfliger, Pascal; Charles, Roch-Philippe (2019). The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer. International journal of molecular sciences, 20(10) Molecular Diversity Preservation International MDPI 10.3390/ijms20102428
|
Text
The L-Type Amino.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (273kB) | Preview |
Chronic proliferation is a major hallmark of tumor cells. Rapidly proliferating cancer cells are highly dependent on nutrients in order to duplicate their cell mass during each cell division. In particular, essential amino acids are indispensable for proliferating cancer cells. Their uptake across the cell membrane is tightly controlled by membrane transporters. Among those, the L-type amino acid transporter LAT1 (SLC7A5) has been repeatedly found overexpressed in a vast variety of cancers. In this review, we summarize the most recent advances in our understanding of the role of LAT1 in cancer and highlight preclinical studies and drug developments underlying the potential of LAT1 as therapeutic target.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Faculty Institutions > NCCR TransCure 04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Biochemistry and Molecular Medicine |
UniBE Contributor: |
Häfliger, Pascal, Charles, Roch-Philippe |
Subjects: |
500 Science > 570 Life sciences; biology 600 Technology > 610 Medicine & health |
ISSN: |
1661-6596 |
Publisher: |
Molecular Diversity Preservation International MDPI |
Language: |
English |
Submitter: |
Barbara Franziska Järmann-Bangerter |
Date Deposited: |
26 Sep 2019 09:36 |
Last Modified: |
05 Dec 2022 15:30 |
Publisher DOI: |
10.3390/ijms20102428 |
PubMed ID: |
31100853 |
Uncontrolled Keywords: |
cancer inhibitor l-type amino acid transporter LAT1 preclinical studies targeted therapy |
BORIS DOI: |
10.7892/boris.133481 |
URI: |
https://boris.unibe.ch/id/eprint/133481 |
Actions (login required)
 |
Edit item |